NeuroBo Pharmaceuticals Inc

NASDAQ:NRBO   11:37:45 AM EDT
3.72
-0.06 (-1.59%)
Earnings Announcements

Neurobo Pharmaceuticals Reports Second Quarter 2021 Financial Results

Published: 08/16/2021 12:39 GMT
NeuroBo Pharmaceuticals Inc (NRBO) - Neurobo Pharmaceuticals Reports Second Quarter 2021 Financial Results.
Q2 Loss per Share $0.18.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.18

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.15

More details on our Analysts Page.